4//SEC Filing
Hirmand Mohammad 4
Accession 0001209191-22-008980
CIK 0001595893other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:08 PM ET
Size
14.0 KB
Accession
0001209191-22-008980
Insider Transaction Report
Form 4
Hirmand Mohammad
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2022-02-09$36.30/sh−669$24,285→ 6,838 total - Award
Common Stock
2022-02-09+18,983→ 25,821 total - Award
Common Stock
2022-02-09+15,000→ 40,821 total - Award
Stock Option (right to buy)
2022-02-09+68,367→ 68,367 totalExercise: $37.68Exp: 2032-02-08→ Common Stock (68,367 underlying)
Footnotes (4)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
- [F2]The Reporting Person acquired 301 shares on June 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 439 shares on December 10, 2021 pursuant to the ESPP.
- [F3]Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
- [F4]1/48th of the shares vest monthly following February 9, 2022.
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001654482
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 6:08 PM ET
- Size
- 14.0 KB